Literature DB >> 32089161

Evidence-based Canadian guidelines for tele-retina screening for diabetic retinopathy: recommendations from the Canadian Retina Research Network (CR2N) Tele-Retina Steering Committee.

M C Boucher1, J Qian2, M H Brent3, D T Wong4, T Sheidow5, R Duval1, A Kherani6, R Dookeran7, D Maberley8, A Samad9, V Chaudhary10.   

Abstract

OBJECTIVE: The purpose of this report is to develop a consensus for Canadian national guidelines specific to a tele-medicine approach to screening for diabetic retinopathy (DR) using evidence-based and clinical data.
METHODS: Canadian Tele-Screening Grading Scales for DR and diabetic macular edema (DME) were created primarily based on severity grading scales outlined by the International Clinical Diabetic Retinopathy Disease Severity Scale (ICDR) and the Scottish DR Grading Scheme 2007. Other grading scales used in international screening programs and the clinical expertise of the Canadian Retina Research Network members and retina specialists nationwide were also used in the creation of the guidelines.
RESULTS: National Tele-Screening Guidelines for DR and DME with and without optical coherence tomography (OCT) images are proposed. These outline a diagnosis and management algorithm for patients presenting with different stages of DR and/or DME. General guidelines detailing the requirements for imaged retina fields, image quality, quality control, and follow-up care and the role of visual acuity, pupil dilation, OCT, ultra-wide-field imaging, and artificial intelligence are discussed.
CONCLUSIONS: Tele-retina screening can help to address the need for timely and effective screening for DR, whose prevalence continues to rise. A standardized and evidence-based national approach to DR tele-screening has been proposed, based on DR/DME grading using two 45° image fields or a single widefield or ultra-wide-field image, preferable use of OCT imaging, and a focus on local quality control measures.
Copyright © 2020 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32089161     DOI: 10.1016/j.jcjo.2020.01.001

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  5 in total

Review 1.  Recently updated global diabetic retinopathy screening guidelines: commonalities, differences, and future possibilities.

Authors:  Taraprasad Das; Brijesh Takkar; Sobha Sivaprasad; Thamarangsi Thanksphon; Hugh Taylor; Peter Wiedemann; Janos Nemeth; Patanjali D Nayar; Padmaja Kumari Rani; Rajiv Khandekar
Journal:  Eye (Lond)       Date:  2021-05-11       Impact factor: 4.456

2. 

Authors:  Daniel Rosenberg; Jason Noble; Varun Chaudhary
Journal:  CMAJ       Date:  2021-09-07       Impact factor: 8.262

3.  Teleretina screening for diabetic retinopathy.

Authors:  Daniel Rosenberg; Jason Noble; Varun Chaudhary
Journal:  CMAJ       Date:  2021-07-05       Impact factor: 8.262

Review 4.  The Role of Telemedicine, In-Home Testing and Artificial Intelligence to Alleviate an Increasingly Burdened Healthcare System: Diabetic Retinopathy.

Authors:  Janusz Pieczynski; Patrycja Kuklo; Andrzej Grzybowski
Journal:  Ophthalmol Ther       Date:  2021-06-22

Review 5.  Telemedicine in ophthalmology in view of the emerging COVID-19 outbreak.

Authors:  Adir C Sommer; Eytan Z Blumenthal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-08-19       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.